Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Highly Active Antiretroviral Therapy (HAART)

Julie S. Eggleton  1 , Shivaraj Nagalli  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Highly Active Antiretroviral Therapy (HAART)

Julie S. Eggleton et al.
Free Books & Documents

Excerpt

Highly active antiretroviral therapy (HAART) is a medication regimen used to manage and treat human immunodeficiency virus type 1 (HIV-1). It is composed of several drugs in the antiretroviral classes of medications. This activity outlines the indications, mechanism of action, and contraindications for various HAART medications in the management of HIV. This activity will highlight the mechanism of action, adverse event profile, and other key factors pertinent to the interprofessional healthcare team members in the care of patients with HIV-1 and related conditions.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Julie Eggleton declares no relevant financial relationships with ineligible companies.

Disclosure: Shivaraj Nagalli declares no relevant financial relationships with ineligible companies.

References

    1. Shafer RW, Vuitton DA. Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomed Pharmacother. 1999 Mar;53(2):73-86. - PubMed
    1. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996 Mar 14;334(11):701-6. - PubMed
    1. Cunningham WE, Tisnado DM, Lui HH, Nakazono TT, Carlisle DM. The effect of hospital experience on mortality among patients hospitalized with acquired immunodeficiency syndrome in California. Am J Med. 1999 Aug;107(2):137-43. - PubMed
    1. Rackal JM, Tynan AM, Handford CD, Rzeznikiewiz D, Agha A, Glazier R. Provider training and experience for people living with HIV/AIDS. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD003938. - PubMed
    1. Ford N, Migone C, Calmy A, Kerschberger B, Kanters S, Nsanzimana S, Mills EJ, Meintjes G, Vitoria M, Doherty M, Shubber Z. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS. 2018 Jan 02;32(1):17-23. - PMC - PubMed

Publication types

LinkOut - more resources